The situation around human iPSC-derived neurons is a little different from that of human iPSC-derived cardiomyocyte. Because iPS-technology is improving so rapidly, honest and deep discussions from industry, government, and academia are required.
The CSRC/HESI/FDA/SPS CIPA Update Workshop on December 11, 2014 in Silver Spring, Maryland was a follow-up meeting to the July 2013 workshop on Rechanneling the Current Cardiac Paradigm. The December update workshop brought together global regulators, academicians, drug developers and CRO scientists
We can’t always travel but we can ALWAYS LEARN!!! For 2015 there are three webinar series opportunities for SPS members who want a better understanding of the cardiovascular system, essential toxicology or CNS pharmacology targets.